ENSG00000167588


Homo sapiens

Features
Gene ID: ENSG00000167588
  
Biological name :GPD1
  
Synonyms : glycerol-3-phosphate dehydrogenase 1 / GPD1 / P21695
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 12
Strand: 1
Band: q13.12
Gene start: 50103819
Gene end: 50111319
  
Corresponding Affymetrix probe sets: 1563034_at (Human Genome U133 Plus 2.0 Array)   1563035_x_at (Human Genome U133 Plus 2.0 Array)   204997_at (Human Genome U133 Plus 2.0 Array)   213706_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000448244
Ensembl peptide - ENSP00000301149
Ensembl peptide - ENSP00000446768
NCBI entrez gene - 2819     See in Manteia.
OMIM - 138420
RefSeq - NM_005276
RefSeq - NM_001257199
RefSeq Peptide - NP_001244128
RefSeq Peptide - NP_005267
swissprot - P21695
swissprot - A0A024R138
swissprot - F8VSE8
Ensembl - ENSG00000167588
  
Related genetic diseases (OMIM): 614480 - Hypertriglyceridemia, transient infantile, 614480
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 gpd1aENSDARG00000043701Danio rerio
 gpd1bENSDARG00000043180Danio rerio
 Gpd1ENSMUSG00000023019Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
GPD1L / Q8N335 / glycerol-3-phosphate dehydrogenase 1 likeENSG0000015264271


Protein motifs (from Interpro)
Interpro ID Name
 IPR006109  Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal
 IPR006168  Glycerol-3-phosphate dehydrogenase, NAD-dependent
 IPR008927  6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
 IPR011128  Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal
 IPR013328  6-phosphogluconate dehydrogenase, domain 2
 IPR017751  Glycerol-3-phosphate dehydrogenase, NAD-dependent, eukaryotic
 IPR036291  NAD(P)-binding domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0005975 carbohydrate metabolic process IEA
 biological_processGO:0006072 glycerol-3-phosphate metabolic process IEA
 biological_processGO:0006094 gluconeogenesis IEA
 biological_processGO:0006116 NADH oxidation IEA
 biological_processGO:0006127 glycerophosphate shuttle IEA
 biological_processGO:0006654 phosphatidic acid biosynthetic process TAS
 biological_processGO:0006734 NADH metabolic process IEA
 biological_processGO:0045821 positive regulation of glycolytic process IEA
 biological_processGO:0046168 glycerol-3-phosphate catabolic process IEA
 biological_processGO:0046486 glycerolipid metabolic process IEA
 biological_processGO:0055114 oxidation-reduction process IEA
 biological_processGO:0071320 cellular response to cAMP IEA
 biological_processGO:0071356 cellular response to tumor necrosis factor IEA
 cellular_componentGO:0005737 cytoplasm IEA
 cellular_componentGO:0005739 mitochondrion IEA
 cellular_componentGO:0005829 cytosol TAS
 cellular_componentGO:0009331 glycerol-3-phosphate dehydrogenase complex IEA
 cellular_componentGO:0070062 extracellular exosome HDA
 molecular_functionGO:0004367 glycerol-3-phosphate dehydrogenase [NAD+] activity TAS
 molecular_functionGO:0004368 glycerol-3-phosphate dehydrogenase (quinone) activity IEA
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor IEA
 molecular_functionGO:0042803 protein homodimerization activity IEA
 molecular_functionGO:0051287 NAD binding IEA


Pathways (from Reactome)
Pathway description
Synthesis of PA


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0001395 Hepatic fibrosis 
Show

 HP:0001397 Hepatic steatosis 
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0002155 Hypertriglyceridemia 
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0003593 Early onset 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000167588 GPD1 / P21695 / glycerol-3-phosphate dehydrogenase 1  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr